YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

VRAX
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

nasdaq.comPOSITIVO

Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch

(RTTNews) - Today's top gainers in the biotech space include CareDx, which rallied after Medicare finalized its Local Coverage Determination process for molecular testing of solid organ allograft rejection; AtaiBeckley, after agreeing to b…

finance.yahoo.comPOSITIVO

Virax Biolabs enters immune profiling product supply deal with Fosun

Virax Biolabs Group subsidiary Virax Biolabs (UK) has signed an exclusive commercial supply agreement with Fosun Diagnostics for its research-use-only ImmuneSelect immune profiling product line. Fosun is the key entity of the diagnostics b…

nasdaq.comPOSITIVO

Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch

(RTTNews) - Today's top biotech gainers include Virax Biolabs, following its agreement with Fosun Diagnostics; Forte Biosciences, after reporting positive vitiligo data; Connect Biopharma, with a key near-term catalyst ahead; and SANUWAVE…

finance.yahoo.comPOSITIVO

Virax Biolabs Stock Skyrockets 100% on Exclusive Distribution Agreement

Biotech research by Gorodenkoff via Shutterstock Virax Biolabs (VRAX) shares ripped higher on July 9 after the company announced an exclusive commercial supply agreement with healthcare heavyweight Fosun Diagnostics. As investors cheered t…

finance.yahoo.comPOSITIVO

Virax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX)

Medical research ©kaboompics.com Virax Biolabs Signs Multi-Country Supply Partnership Virax Biolabs Group Limited (NASDAQ:VRAX) shares surged 100% on Thursday after the company announced an exclusive commercial supply agreement with Fosun…

nasdaq.comPOSITIVO

Virax Signs Multi-Country Commercial Supply Agreement With Fosun Diagnostics; Stock Skyrockets

(RTTNews) - Virax Biolabs Group Limited (VRAX) announced that its wholly owned subsidiary, Virax Biolabs (UK) Limited, has entered into an exclusive multi-country commercial supply agreement with Fosun Diagnostics for its ImmuneSelect immu…

nasdaq.comPOSITIVO

Pre-Market Movers: TNGX, WOK, GOCO Set The Path

(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday, hinting at possible breakout opportunities. Assessing sentiment and momentum in the premarket sets the tone for a trader's day. Price swings ahead of the…

nasdaq.comPOSITIVO

Virax Biolabs Unveils $5 Million Private Placement

(RTTNews) - Virax Biolabs Group Limited (VRAX) announced on Thursday that it has entered into a definitive agreement for the purchase and sale of 12.5 million shares at the price of $0.40 per share for expected gross proceeds of $5 million…

finance.yahoo.comPOSITIVO

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Virax Biolabs Group Ltd 192,497,473 0.87 0.6039 0.6548 +0.2619 Paranovus E…

finance.yahoo.comPOSITIVO

Virax Biolabs (VRAX) Falls 18% on Lack of Leads

We recently published 10 Stocks Losing Big. Virax Biolabs Group Ltd. (NASDAQ:VRAX) is one of the worst performers of Tuesday. Virax Biolabs snapped a two-day winning streak on Tuesday, shedding 18.18 percent to close at $0.6333 apiece as i…

seekingalpha.comNEGATIVO

Virax Biolabs receives Nasdaq letter over non-compliance with minimum bid price rule

* Virax Biolabs Group (NASDAQ:VRAX [https://seekingalpha.com/symbol/VRAX]) received a notice from Nasdaq notifying the company that it is not in compliance with its minimum bid price requirement. * The company has a compliance period of on…

finance.yahoo.comPOSITIVO

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

LONDON, July 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced that i…

seekingalpha.comPOSITIVO

FibroBiologics announces CFO appointment

* FibroBiologics (NASDAQ:FBLG [https://seekingalpha.com/symbol/FBLG]) announced the appointment of Jason D. Davis, CPA, as chief financial officer, effective immediately. * Davis most recently served as CFO of Virax Biolabs (VRAX [https://…

finance.yahoo.comPOSITIVO

10 Biotech Stocks With The Biggest Upside

In this article, we discuss the 10 biotech stocks with the biggest upside. If you want to read about some more biotech stocks with the biggest upside, go directly to 5 Biotech Stocks With The Biggest Upside. The biotechnology sector has be…

finance.yahoo.comNEGATIVO

Weekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion

The global tally of COVID cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the World Health Organization said in its weekly update on the virus. Continue reading

finance.yahoo.comPOSITIVO

Why Is Renovacor (RCOR) Stock Up 18% Today?

Renovacor (NYSEMKT:RCOR) stock is gaining on Tuesday after announcing that Rocket Pharmaceuticals (NASDAQ:RCKT) is acquiring it. That agreement will have Rocket Pharmaceuticals offering 0.1676 shares of RCKT stock in exchange for each outs…

finance.yahoo.comPOSITIVO

10 Best Penny Stocks to Buy in September

In this article, we will take a look at the 10 best penny stocks to buy in September. If you want to skip our discussion on the current US economic situation, go directly to the 5 Best Penny Stocks to Buy in September. The US equity market…

globenewswire.comPOSITIVO

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

London, United Kingdom, July 26, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, tod…

globenewswire.comPOSITIVO

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

London, United Kingdom, July 21, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, tod…

globenewswire.comPOSITIVO

Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

London, United Kingdom, July 20, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, tod…